Cromos Pharma’s CEO to Present at the 17th BioPharma Nexus Conference
Cromos Pharma’s CEO to present at the 17th BioPharma Nexus Conference, which is set to take place June 15-16, 2023 in Amsterdam, Netherlands.
Cromos Pharma’s CEO Vlad Bogin, MD, FACP will be participating as a speaker in the panel discussion “How to put Patients in the Heart of Clinical Trials & Daily Practice?”.
Vlad is looking forward to meeting partners and potential clients and learn about their clinical development plans. Reach out to us directly at inquiry@cromospharma.com to set up a meeting to discuss your next clinical trial.
BioPharma Nexus is a conference that brings together key decision-makers and senior clinical trials professionals to share ideas and make connections with Clinical CROs/Service Providers. The agenda of the conference is focused on advancements and innovative solutions in all aspects of clinical research.
About Cromos Pharma
Cromos Pharma is a US-based, international contract research organization delivering fully integrated clinical research solutions, in all trial phases, across a wide range of therapeutic indications. Our expert team, comprised of 95% MDs, has extensive expertise in study design, medical writing, regulatory affairs, site management, patient recruitment and data management.
Cromos Pharma has experience in delivering success in a wide range of trial types, from biosimilars and generics, to successfully managing trials of novel therapeutics in a wide range of clinical indications. Our team provides full-service solutions to international pharma and biotech companies in high-recruiting regions, assuring exceptional data quality. Cromos Pharma combines global expertise with in-depth experience and knowledge in the US, Central and Eastern Europe, Central Asia, Republic of Georgia, and Türkiye resulting in rapid patient recruitment. Our team has met or reduced enrollment timelines in 95% of conducted trials.
We provide accelerated study start-up timelines in our regions of operation. Regulatory inspections by FDA and EMA and site audits attest to the highest quality of our clinical data.
Established in 2004, Cromos Pharma has strong regional experience that is supported by a global network of offices. Its international HQ is in Portland, Oregon, USA and its European HQ is in Dublin, Ireland.
